Amir A Dastgah, DPM
Podiatry · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 34
- 10 carriers
- Office
- 1
Offices
1 location · Bay Area Foot and Ankle Centers Inc · 3 clinicians in this group
Hospitals listed: Community Hospital of the Monterey Peninsula · El Camino Health · Washington Hospital. That is not proof they admit you there this week.
Plans that list them
34 plans · 10 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Dastgah’s office at (510) 794-6633 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
34 of 34 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Community Hospital of the Monterey PeninsulaMonterey, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Montage HealthPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.48 (1.22 to 1.74), Jul 2022 – Jun 2024Worse than the national rate — Postoperative acute kidney injury requiring dialysis rate: 3.12 (1.69 to 4.56) · 1,095 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 19.24 (14.17 to 24.3) · 1,118 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative sepsis rate: 9.62 (6.42 to 12.82) · 1,086 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.39, Oct 2024 – Sep 2025
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Washington HospitalFremont, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Washington Hospital Healthcare SystemPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.188, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.164, Oct 2024 – Sep 2025
See every measure and the patient survey for Community Hospital of the Monterey Peninsula
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 11 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.48 (1.22 to 1.74) | Worse | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 3.12 (1.69 to 4.56) · 1,095 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 19.24 (14.17 to 24.3) · 1,118 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 9.62 (6.42 to 12.82) · 1,086 cases | Worse | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.39 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.27 (0.39 to 2.16) · 1,873 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 158.2 (110.65 to 205.75) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 74 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.7 · 686 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 1,072 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8 · 328 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 3,300 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.11 to 0.48) · 10,234 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.46) · 10,572 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.25 (1.47 to 5.04) · 2,617 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.37 (1.04 to 3.7) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.21 (0.75 to 3.66) · 744 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.61 (0.06 to 1.17) · 8,715 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.2 · 156 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.28 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.799 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.732 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 152 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 625 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 6.3 · 193 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.2 · 749 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7 · 1,074 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 850 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4 (2.7 to 5.8) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.5 (10.4 to 17.4) · 224 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 153 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.5 · 49 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.9 to 18.6) · 711 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 746 cases | No different | Jan 2024 – Dec 2024 |
What patients said (520 patients answered, 28% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 5 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 79% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Washington Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.188 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.164 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.88) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.59 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.95 (139.54 to 246.36) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 164 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 661 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 174 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 2,550 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 6,970 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,108 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.73 to 5.91) · 1,370 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.52 (0 to 3.17) · 589 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.75 (0.25 to 3.25) · 1,315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.19 (5.83 to 20.56) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.91 (1.04 to 8.78) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 6,079 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 114 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.367 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 480 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 33.9 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.5 · 553 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 36.8 · 648 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 590 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.2 to 6.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 14.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 202 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.2 to 18.5) · 78 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 974 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$143,753
Medicare paid this office $143,753 for 625 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 254 | $37,379 | $72 |
| Removal of noncancer thickened skin growth, 2-4 growths | 123 | $18,064 | $66 |
| Removal of fingernails or toenails, 6 or more nails | 196 | $17,847 | $34 |
| New patient visit (30+ min) | 205 | $15,165 | $74 |
| Removal of skin and tissue, 20.0 sq cm or less | 22 | $14,552 | $116 |
See all 18 services
| Short return visit (20+ min) | 254 | $37,379 | $72 |
| Removal of noncancer thickened skin growth, 2-4 growths | 123 | $18,064 | $66 |
| Removal of fingernails or toenails, 6 or more nails | 196 | $17,847 | $34 |
| New patient visit (30+ min) | 205 | $15,165 | $74 |
| Removal of skin and tissue, 20.0 sq cm or less | 22 | $14,552 | $116 |
| X-ray of foot, minimum of 3 views | 136 | $6,829 | $29 |
| Removal of noncancer thickened skin growth, 1 growth | 44 | $4,162 | $58 |
| Ultrasound study of arm and leg arteries | 51 | $3,701 | $73 |
| Permanent removal fingernail or toenail | 22 | $3,093 | $129 |
| Muscle electrical test | 16 | $2,673 | $86 |
| Short return visit | 37 | $2,508 | $43 |
| Nerve test | 16 | $2,385 | $149 |
| Return visit (30+ min) | 16 | $2,093 | $105 |
| Removal of fingernails or toenails, 1-5 nails | 30 | $1,497 | $26 |
| Injection into tendon or ligament | 14 | $817 | $45 |
| X-ray of ankle, minimum of 3 views | 13 | $649 | $29 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 31 | $47 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 31 | $5 | None |
Procedures Medicare counted
| Removal of nail tissue | 516 | More than 84% of doctors who do this |
| Removal of skin lesions | 1-10 | None |
| Removal of tissue | 24 | More than 71% of doctors who do this |
| Removal or shaving of skin growth | 234 | More than 91% of doctors who do this |
Who their Medicare patients are
625 Original Medicare patients in 2024. Average age 76 · Under 65 7% · 85 and older 23% · Women 59% · Also on Medicaid 31% · Health risk score 1.61. Above the middle of the specialty; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 75% · Diabetes 44% · Coronary heart disease 32% · Chronic kidney disease 30% · Heart failure 22% · Atrial fibrillation 20% · Depression 17% · COPD 16% · Cancer 15% · Dementia 11% · Stroke 10%.
The office billed $419,257, Medicare allowed $203,235 and paid $143,753; for 2,501 services of 49 kinds; $53 of it was for drugs given in the office and $143,701 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 625 | 2,501 | 76 | 1.61 | $419,257 | $143,753 |
| 2023 | 544 | 2,087 | 77 | 1.44 | $351,927 | $135,807 |
| 2022 | 462 | 2,021 | 77 | 1.29 | $363,818 | $135,229 |
| 2021 | 320 | 1,736 | 78 | 1.52 | $289,764 | $121,654 |
| 2020 | 332 | 1,706 | 77 | 1.77 | $288,957 | $98,515 |
| 2019 | 383 | 2,370 | 77 | 1.66 | $391,990 | $132,048 |
| 2018 | 437 | 2,490 | 77 | 1.62 | $293,823 | $133,918 |
| 2017 | 365 | 2,455 | 78 | 1.65 | $282,775 | $137,155 |
| 2016 | 314 | 2,368 | 79 | 1.56 | $265,652 | $146,749 |
| 2015 | 284 | 1,967 | 78 | 1.49 | $206,839 | $106,990 |
| 2014 | 273 | 1,782 | 78 | 1.34 | $223,170 | $116,205 |
| 2013 | 155 | 873 | 79 | 1.27 | $109,737 | $60,408 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 17 services
| Short return visit (20+ min) | 188 | $37,241 | $79 |
| Removal of noncancer thickened skin growth, 2-4 growths | 112 | $17,409 | $78 |
| Removal of fingernails or toenails, 6 or more nails | 175 | $16,205 | $40 |
| New patient visit (30+ min) | 175 | $15,851 | $91 |
| Removal of skin and tissue, 20.0 sq cm or less | 13 | $8,078 | $128 |
| X-ray of foot, minimum of 3 views | 114 | $6,580 | $32 |
| Short return visit | 54 | $4,098 | $52 |
| Removal of noncancer thickened skin growth, 1 growth | 32 | $3,615 | $70 |
| Permanent removal fingernail or toenail | 18 | $3,090 | $134 |
| Ultrasound study of arm and leg arteries | 34 | $2,731 | $78 |
| Muscle electrical test | 13 | $2,245 | $94 |
| Nerve test | 13 | $1,950 | $150 |
| Removal of fingernails or toenails, 1-5 nails | 28 | $1,710 | $30 |
| X-ray of ankle, minimum of 3 views | 12 | $568 | $38 |
| Imaging guidance for procedure, 60 minutes or less | 11 | $150 | $14 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 25 | $30 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 27 | $4 | None |
2022: 16 services
| Short return visit (20+ min) | 182 | $28,586 | $81 |
| Removal of fingernails or toenails, 6 or more nails | 183 | $15,898 | $37 |
| Removal of noncancer thickened skin growth, 2-4 growths | 85 | $14,997 | $81 |
| New patient visit (30+ min) | 126 | $10,855 | $86 |
| Removal of skin and tissue, 20.0 sq cm or less | 18 | $10,314 | $127 |
| X-ray of foot, minimum of 3 views | 99 | $6,281 | $33 |
| Return visit (30+ min) | 32 | $4,489 | $112 |
| Short return visit | 50 | $3,865 | $52 |
| New patient visit (45+ min) | 30 | $3,148 | $105 |
| Removal of noncancer thickened skin growth, 1 growth | 25 | $2,417 | $62 |
| Removal of fingernails or toenails, 1-5 nails | 28 | $1,750 | $30 |
| X-ray of foot, 2 views | 21 | $932 | $25 |
| X-ray of ankle, minimum of 3 views | 13 | $752 | $36 |
| Imaging guidance for procedure, 60 minutes or less | 12 | $162 | $13 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 18 | $29 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 18 | $3 | None |
2021: 15 services
| Short return visit (20+ min) | 132 | $22,634 | $85 |
| Removal of noncancer thickened skin growth, 2-4 growths | 81 | $17,904 | $82 |
| Removal of fingernails or toenails, 6 or more nails | 153 | $15,113 | $42 |
| Removal of skin and tissue, 20.0 sq cm or less | 21 | $12,050 | $130 |
| Return visit (30+ min) | 46 | $9,733 | $122 |
| New patient visit (30+ min) | 61 | $6,037 | $99 |
| X-ray of foot, minimum of 3 views | 61 | $4,069 | $35 |
| Short return visit | 42 | $4,012 | $51 |
| Removal of tissue from wound, 20.0 sq cm or less | 16 | $3,291 | $100 |
| New patient visit (45+ min) | 21 | $3,251 | $155 |
| Removal of noncancer thickened skin growth, 1 growth | 23 | $2,728 | $68 |
| Removal of fingernails or toenails, 1-5 nails | 21 | $1,512 | $32 |
| X-ray of foot, 2 views | 23 | $968 | $28 |
| New patient visit (15+ min) | 12 | $842 | $70 |
| Application of ultrasound, each 15 minutes | 20 | $834 | $14 |
2020: 15 services
| Short return visit (20+ min) | 133 | $19,434 | $66 |
| Removal of noncancer thickened skin growth, 2-4 growths | 109 | $15,462 | $68 |
| Removal of fingernails or toenails, 6 or more nails | 165 | $13,063 | $40 |
| Removal of skin and tissue, 20.0 sq cm or less | 20 | $7,694 | $115 |
| New patient visit (30+ min) | 51 | $4,394 | $86 |
| Short return visit | 56 | $3,917 | $42 |
| X-ray of foot, minimum of 3 views | 47 | $3,545 | $31 |
| Removal of tissue from wound, 20.0 sq cm or less | 17 | $3,320 | $98 |
| Removal of noncancer thickened skin growth, 1 growth | 33 | $2,777 | $57 |
| New patient visit (45+ min) | 12 | $1,493 | $124 |
| New patient visit (15+ min) | 23 | $1,414 | $61 |
| Removal of fingernails or toenails, 1-5 nails | 28 | $1,163 | $29 |
| X-ray of foot, 2 views | 20 | $953 | $26 |
| Placement of strapping to toes | 17 | $671 | $16 |
| Trimming of fingernails or toenails | 11 | $131 | $9 |
2019: 18 services
| Short return visit (20+ min) | 189 | $32,234 | $65 |
| Removal of fingernails or toenails, 6 or more nails | 160 | $16,347 | $41 |
| Removal of skin and tissue, 20.0 sq cm or less | 36 | $15,388 | $95 |
| Removal of noncancer thickened skin growth, 2-4 growths | 111 | $14,497 | $61 |
| Short return visit | 127 | $9,794 | $41 |
| New patient visit (30+ min) | 71 | $6,392 | $90 |
| Removal of noncancer thickened skin growth, 1 growth | 47 | $4,055 | $54 |
| Return visit (30+ min) | 16 | $3,753 | $77 |
| X-ray of foot, minimum of 3 views | 53 | $3,392 | $31 |
| New patient visit (45+ min) | 19 | $2,356 | $124 |
| Removal of noncancer thickened skin growth, more than 4 growths | 11 | $1,643 | $71 |
| Removal of fingernails or toenails, 1-5 nails | 28 | $1,641 | $32 |
| X-ray of foot, 2 views | 34 | $1,529 | $27 |
| New patient visit (15+ min) | 19 | $1,312 | $69 |
| Placement of strapping to ankle or foot | 13 | $510 | $26 |
| Trimming of fingernails or toenails | 15 | $325 | $12 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $15 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 14 | $2 | None |
2018: 13 services
| Short return visit (20+ min) | 337 | $62,653 | $60 |
| Removal of noncancer thickened skin growth, 2-4 growths | 197 | $23,372 | $51 |
| New patient visit (30+ min) | 173 | $15,070 | $87 |
| Removal of skin and tissue, 20.0 sq cm or less | 17 | $4,095 | $62 |
| Removal of fingernails or toenails, 6 or more nails | 89 | $3,683 | $39 |
| Return visit (30+ min) | 18 | $2,709 | $77 |
| X-ray of foot, minimum of 3 views | 45 | $2,038 | $26 |
| X-ray of foot, 2 views | 35 | $1,819 | $24 |
| Permanent removal fingernail or toenail | 11 | $1,622 | $135 |
| Short return visit | 33 | $1,591 | $39 |
| Removal of noncancer thickened skin growth, 1 growth | 28 | $1,542 | $44 |
| Placement of strapping to ankle or foot | 25 | $1,202 | $23 |
| Placement of strapping to toes | 18 | $682 | $19 |
2017: 14 services
| Short return visit (20+ min) | 300 | $55,531 | $57 |
| Removal of noncancer thickened skin growth, 2-4 growths | 203 | $30,471 | $49 |
| Removal of fingernails or toenails, 6 or more nails | 93 | $9,790 | $39 |
| New patient visit (30+ min) | 89 | $7,351 | $83 |
| Removal of skin and tissue, 20.0 sq cm or less | 18 | $2,996 | $68 |
| Removal of tissue from wound, 20.0 sq cm or less | 21 | $2,906 | $63 |
| Return visit (30+ min) | 17 | $1,738 | $79 |
| X-ray of foot, minimum of 3 views | 33 | $1,555 | $25 |
| X-ray of foot, 2 views | 25 | $1,347 | $23 |
| Short return visit | 27 | $1,051 | $35 |
| Placement of strapping to ankle or foot | 18 | $739 | $23 |
| Removal of noncancer thickened skin growth, 1 growth | 15 | $656 | $39 |
| Injection into tendon or ligament | 11 | $612 | $47 |
| Removal of fingernails or toenails, 1-5 nails | 14 | $590 | $28 |
2016: 11 services
| Short return visit (20+ min) | 248 | $54,391 | $60 |
| Removal of noncancer thickened skin growth, 2-4 growths | 200 | $31,575 | $51 |
| Removal of fingernails or toenails, 6 or more nails | 70 | $8,951 | $41 |
| New patient visit (30+ min) | 78 | $6,475 | $83 |
| Removal of tissue from wound, 20.0 sq cm or less | 13 | $3,674 | $71 |
| Removal of skin and tissue, 20.0 sq cm or less | 13 | $3,365 | $89 |
| Return visit (30+ min) | 16 | $1,589 | $88 |
| X-ray of foot, minimum of 3 views | 29 | $1,402 | $25 |
| Short return visit | 22 | $882 | $35 |
| Placement of strapping to ankle or foot | 16 | $683 | $23 |
| X-ray of foot, 2 views | 14 | $467 | $25 |
2015: 11 services
| Short return visit (20+ min) | 224 | $48,902 | $60 |
| Removal of noncancer thickened skin growth, 2-4 growths | 175 | $20,964 | $50 |
| Removal of fingernails or toenails, 6 or more nails | 77 | $7,922 | $38 |
| Removal of tissue from wound, 20.0 sq cm or less | 13 | $5,533 | $69 |
| New patient visit (30+ min) | 66 | $5,507 | $83 |
| X-ray of foot, minimum of 3 views | 43 | $2,299 | $26 |
| Return visit (30+ min) | 14 | $1,108 | $74 |
| Placement of strapping to ankle or foot | 28 | $1,035 | $22 |
| Short return visit | 20 | $974 | $35 |
| X-ray of foot, 2 views | 14 | $593 | $24 |
| Placement of strapping to toes | 13 | $341 | $15 |
2014: 10 services
| Short return visit (20+ min) | 209 | $37,631 | $65 |
| Return visit (30+ min) | 141 | $23,927 | $90 |
| Removal of noncancer thickened skin growth, 2-4 growths | 116 | $12,313 | $54 |
| Removal of fingernails or toenails, 6 or more nails | 116 | $9,947 | $39 |
| New patient visit (45+ min) | 67 | $9,099 | $136 |
| Removal of tissue from wound, 20.0 sq cm or less | 14 | $4,862 | $74 |
| X-ray of foot, minimum of 3 views | 35 | $2,166 | $31 |
| Placement of strapping to ankle or foot | 24 | $1,960 | $37 |
| Short return visit | 18 | $955 | $40 |
| Placement of strapping to toes | 16 | $409 | $19 |
2013: 9 services
| Short return visit (20+ min) | 56 | $11,017 | $66 |
| New patient visit (45+ min) | 67 | $9,586 | $143 |
| Return visit (30+ min) | 41 | $8,275 | $99 |
| Removal of fingernails or toenails, 6 or more nails | 55 | $4,670 | $42 |
| Removal of noncancer thickened skin growth, 2-4 growths | 42 | $4,086 | $58 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 15 | $1,666 | $72 |
| X-ray of foot, minimum of 3 views | 21 | $1,376 | $33 |
| Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | 18 | $1,242 | $62 |
| New patient custodial care facility, group care, or assisted living visit, typically 30 minutes | 12 | $785 | $65 |
Medicaid work
$4,796 in 2024
Medicaid paid $4,796 for 552 billed services this clinician did in 2024, up to 38 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (30+ min) | 128 | $2,036 |
| Short return visit (20+ min) | 342 | $1,747 |
| Debridement of nail(s) by any method(s); 6 or more | 67 | $985 |
| X-RAY EXAM OF FOOT | 15 | $28 |
| 2024 | 552 | 4 | 38 | $4,796 |
| 2023 | 742 | 5 | 45 | $6,452 |
| 2022 | 211 | 4 | 26 | $1,392 |
| 2018 | 23 | 1 | 23 | $0 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 468 | $2,627 |
| New patient visit (30+ min) | 174 | $2,065 |
| Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each | 24 | $955 |
| Debridement of nail(s) by any method(s); 6 or more | 42 | $697 |
| X-RAY EXAM OF FOOT | 34 | $108 |
2022
| Short return visit (20+ min) | 128 | $769 |
| X-RAY EXAM OF FOOT | 52 | $340 |
| New patient visit (30+ min) | 15 | $208 |
| Return visit (30+ min) | 16 | $75 |
2018
| Debridement of nail(s) by any method(s); 6 or more | 23 | $0 |
Drugs they prescribed that Part D paid
$44,023
Pharmacies billed $44,023 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 821) in 2024. At or below the middle of the specialty; the typical podiatry clinician is at 5%.
788 generic and 33 brand-name prescriptions · $44,023 in drug cost · 77 antibiotic prescriptions to 60 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jublia | 15 | $23,160 | $1,103 |
| Clotrimazole | 191 | $12,117 | $24 |
| Diclofenac | 28 | $1,476 | $36 |
| Mupirocin | 41 | $451 | $8 |
| Terbinafine | 17 | $335 | $12 |
See all 8 drugs
| Jublia | 15 | $23,160 | $1,103 |
| Clotrimazole | 191 | $12,117 | $24 |
| Diclofenac | 28 | $1,476 | $36 |
| Mupirocin | 41 | $451 | $8 |
| Terbinafine | 17 | $335 | $12 |
| Amoxicillin-Clavulanate Potass | 47 | $327 | $6 |
| Meloxicam | 47 | $216 | $3 |
| Cephalexin | 11 | $60 | $4 |
Year by year
| 2024 | 821 | 320 | 0% (0) | 4% | $44,023 |
| 2023 | 557 | 246 | 0% (0) | 4% | $34,890 |
| 2022 | 163 | 88 | 0% (0) | None | $11,447 |
| 2021 | 384 | 136 | None | None | $42,713 |
| 2020 | 286 | 114 | None | 7% | $23,280 |
| 2019 | 357 | 112 | None | 12% | $27,676 |
| 2018 | 296 | 123 | 4% (11) | 17% | $31,379 |
| 2017 | 230 | 106 | 8% (18) | 20% | $24,261 |
| 2016 | 157 | 83 | None | 25% | $16,813 |
| 2015 | 145 | 73 | None | 27% | $12,095 |
| 2014 | 136 | 73 | None | None | $7,857 |
| 2013 | 62 | 32 | None | 21% | $2,376 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Clotrimazole | 334 | $9,767 | $29 |
| Santyl | 11 | $7,836 | $712 |
| Diclofenac | 65 | $3,223 | $50 |
| Mupirocin | 23 | $213 | $9 |
| Terbinafine | 17 | $211 | $12 |
| Amoxicillin-Clavulanate Potass | 27 | $195 | $7 |
| Meloxicam | 46 | $152 | $3 |
2022: 1 drug
| Clotrimazole | 103 | $3,109 | $30 |
2021: 7 drugs
| Jublia | 16 | $20,577 | $1,286 |
| Santyl | 12 | $7,685 | $640 |
| Clotrimazole | 224 | $7,593 | $34 |
| Diclofenac | 33 | $861 | $26 |
| Mupirocin | 22 | $256 | $12 |
| Meloxicam | 24 | $158 | $7 |
| Amoxicillin-Clavulanate Potass | 13 | $136 | $10 |
2020: 4 drugs
| Clotrimazole | 166 | $5,961 | $36 |
| Diclofenac | 33 | $1,007 | $31 |
| Mupirocin | 15 | $134 | $9 |
| Amoxicillin-Clavulanate Potass | 11 | $109 | $10 |
2019: 8 drugs
| Jublia | 18 | $12,413 | $690 |
| Clotrimazole | 178 | $6,924 | $39 |
| Santyl | 14 | $3,913 | $279 |
| Diclofenac | 29 | $920 | $32 |
| Amoxicillin-Clavulanate Potass | 26 | $300 | $12 |
| Meloxicam | 21 | $169 | $8 |
| Mupirocin | 15 | $135 | $9 |
| Ibuprofen | 14 | $90 | $6 |
2018: 6 drugs
| Clotrimazole | 141 | $6,323 | $45 |
| Santyl | 13 | $4,149 | $319 |
| Diclofenac | 18 | $521 | $29 |
| Amoxicillin-Clavulanate Potass | 29 | $297 | $10 |
| Mupirocin | 14 | $148 | $11 |
| Meloxicam | 12 | $106 | $9 |
2017: 4 drugs
| Clotrimazole | 95 | $4,046 | $43 |
| Voltaren | 12 | $624 | $52 |
| Amoxicillin-Clavulanate Potass | 29 | $394 | $14 |
| Oxycodone-Acetaminophen | 13 | $237 | $18 |
2016: 4 drugs
| Lyrica | 12 | $8,350 | $696 |
| Clotrimazole | 62 | $2,715 | $44 |
| Voltaren | 20 | $981 | $49 |
| Amoxicillin-Clavulanate Potass | 18 | $253 | $14 |
2015: 4 drugs
| Ciclopirox | 19 | $1,260 | $66 |
| Voltaren | 21 | $980 | $47 |
| Clotrimazole | 33 | $960 | $29 |
| Amoxicillin-Clavulanate Potass | 25 | $350 | $14 |
2014: 3 drugs
| Voltaren | 23 | $1,167 | $51 |
| Clotrimazole | 52 | $929 | $18 |
| Amox Tr-Potassium Clavulanate | 17 | $272 | $16 |
2013: 1 drug
| Clotrimazole | 33 | $533 | $16 |
Money from drug and device companies
$712 in 2025
| 2025 | 9 | 33 | None | $712 |
| 2024 | 12 | 36 | None | $717 |
| 2023 | 12 | 35 | None | $702 |
| 2022 | 14 | 45 | None | $1,031 |
| 2021 | 11 | 46 | None | $1,577 |
| 2020 | 10 | 39 | None | $6,212 |
| 2019 | 14 | 41 | None | $3,469 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Smith+Nephew | Collagenase Santyl | $236 | 11 payments
|
| Amgen | Krystexxa | $152 | 8 payments
|
| Stryker | Ortholoc 2 Lapifuse | $80 | 3 payments
|
| Orthofix Medical | Physio-Stim | $58 | 4 payments
|
| DePuy Synthes Sales | Motoband | $52 | 2 payments
|
| Paratek Pharmaceuticals | Nuzyra | $49 | 2 payments
|
See all 33 published payments
| Smith+Nephew | Meals · 2025-12-26 | Collagenase Santyl | $7 |
| Smith+Nephew | Meals · 2025-11-24 | Collagenase Santyl | $19 |
| Amgen | Meals · 2025-11-19 | Krystexxa | $7 |
| Orthofix Medical | Meals · 2025-11-07 | Physio-Stim | $13 |
| Amgen | Meals · 2025-11-03 | Krystexxa | $14 |
| Globus Medical | Meals · 2025-09-30 | Senza | $29 |
| Smith+Nephew | Meals · 2025-09-22 | Collagenase Santyl | $30 |
| Amgen | Meals · 2025-09-19 | Krystexxa | $12 |
| DePuy Synthes Sales | Meals · 2025-09-15 | Motoband | $26 |
| Stryker | Meals · 2025-09-09 | Ortholoc 2 Lapifuse | $16 |
| Smith+Nephew | Meals · 2025-09-09 | Collagenase Santyl | $9 |
| Smith+Nephew | Meals · 2025-09-09 | Grafix | $43 |
| Amgen | Meals · 2025-08-29 | Krystexxa | $20 |
| Molnlycke Health Care US | Meals · 2025-08-25 | Mepilex Border Flex | $39 |
| Smith+Nephew | Meals · 2025-08-19 | Collagenase Santyl | $7 |
| Amgen | Meals · 2025-08-15 | Krystexxa | $30 |
| Stryker | Meals · 2025-07-29 | Ortholoc 2 Lapifuse | $39 |
| DePuy Synthes Sales | Meals · 2025-07-18 | Motoband | $26 |
| Smith+Nephew | Meals · 2025-06-16 | Collagenase Santyl | $23 |
| Paratek Pharmaceuticals | Meals · 2025-06-09 | Nuzyra | $26 |
| Amgen | Meals · 2025-06-06 | Krystexxa | $30 |
| Orthofix Medical | Meals · 2025-05-02 | Physio-Stim | $7 |
| Smith+Nephew | Meals · 2025-04-22 | Stravix | $24 |
| Amgen | Meals · 2025-04-04 | Krystexxa | $25 |
| Orthofix Medical | Meals · 2025-04-04 | Physio-Stim | $24 |
| Orthofix Medical | Meals · 2025-03-14 | Physio-Stim | $14 |
| Medtronic | Meals · 2025-03-13 | Rapidvac | $18 |
| Smith+Nephew | Meals · 2025-03-03 | Stravix | $46 |
| Smith+Nephew | Meals · 2025-03-03 | Stravix | $13 |
| Amgen | Meals · 2025-02-07 | Krystexxa | $14 |
| Smith+Nephew | Meals · 2025-02-03 | Collagenase Santyl | $15 |
| Paratek Pharmaceuticals | Meals · 2025-01-17 | Nuzyra | $23 |
| Stryker | Meals · 2025-01-13 | Ortholoc 3di | $25 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $717
| Smith+Nephew | Collagenase Santyl | $193 | 14 payments
|
| Paratek Pharmaceuticals | Nuzyra | $90 | 4 payments
|
| Organogenesis | None | $70 | 3 payments
|
| MIMEDX Group | None | $69 | 2 payments
|
| ConvaTec | Innovamatrix Ac | $65 | 3 payments
|
| Amgen | Krystexxa | $47 | 2 payments
|
| Biotissue Holdings | None | $40 | 1 payment
|
| Orthofix Medical | Physio-Stim | $38 | 2 payments
|
| Reprise Biomedical | Miro3d | $38 | 2 payments
|
| Bioventus | Exogen Ultrasound Bone Healing System | $26 | 1 payment
|
| Paragon 28 | Portfolio | $25 | 1 payment
|
| Curonix | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A | $17 | 1 payment
|
2023: $702
| Smith+Nephew | Collagenase Santyl | $200 | 13 payments
|
| Organogenesis | Puraply | $181 | 9 payments
|
| Biotissue Holdings | Neox | $58 | 2 payments
|
| ConvaTec | Innovamatrix Ac | $57 | 2 payments
|
| Orthofix Medical | Physio-Stim | $46 | 2 payments
|
| Musculoskeletal Transplant Foundation | None | $44 | 1 payment
|
| Medtronic | Intellis Adaptivestim | $25 | 1 payment
|
| Electronic Waveform Lab | None | $25 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $21 | 1 payment
|
| Hartmann USA | Zetuvit Plus | $18 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $14 | 1 payment
|
| Paragon 28 | Mtp | $13 | 1 payment
|
2022: $1,031
| Smith+Nephew | Grafix Pl | $336 | 18 payments
|
| Musculoskeletal Transplant Foundation | None | $304 | 9 payments
|
| Bioventus | Exogen Ultrasound Bone Healing System | $98 | 5 payments
|
| Alfasigma USA | None | $60 | 2 payments
|
| Treace Medical Concepts | Lapiplasty System | $43 | 2 payments
|
| Orthofix Medical | Physio-Stim | $41 | 1 payment
|
| Medtronic | Accurian | $31 | 1 payment
|
| Triad Life Sciences | Innovamatrix Ac | $22 | 1 payment
|
| Kowa Pharmaceuticals America | Seglentis | $18 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $18 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $17 | 1 payment
|
| Resmed | Air 11 | $17 | 1 payment
|
| Nevro | Omnia | $15 | 1 payment
|
| ConvaTec | Aquacel Ag+ | $12 | 1 payment
|
2021: $1,577
| Treace Medical Concepts | Lapiplasty System | $714 | 6 payments
|
| Smith+Nephew | Stravix | $319 | 20 payments
|
| Musculoskeletal Transplant Foundation | None | $318 | 9 payments
|
| Organogenesis | Puraply Antimicrobial | $49 | 2 payments
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $40 | 2 payments
|
| In2Bones USA | Colink | $34 | 1 payment
|
| Bioventus | Exogen Ultrasound Bone Healing System | $32 | 2 payments
|
| Alfasigma USA | None | $23 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $22 | 1 payment
|
| Misonix | None | $14 | 1 payment
|
| Orthofix Medical | Physio-Stim | $11 | 1 payment
|
2020: $6,212
| Arthrex | None | $4,579 | 10 payments
|
| Evolution Surgical | None | $1,032 | 5 payments
|
| Smith+Nephew | Stravix | $233 | 12 payments
|
| Musculoskeletal Transplant Foundation | None | $161 | 2 payments
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $72 | 3 payments
|
| Organogenesis | Puraply | $43 | 2 payments
|
| Horizon Therapeutics plc | Krystexxa | $41 | 2 payments
|
| Bioventus | Exogen | $20 | 1 payment
|
| Amniox Medical | Neox | $16 | 1 payment
|
| Integra LifeSciences | Bilayer Wound Matrix (Bwm) | $15 | 1 payment
|
2019: $3,469
| Evolution Surgical | None | $2,936 | 1 payment
|
| Smith+Nephew | Santyl | $139 | 12 payments
|
| Sandoz | Kerydin | $122 | 13 payments
|
| Horizon Therapeutics plc | Krystexxa | $74 | 3 payments
|
| Crossroads Extremity Systems | None | $32 | 2 payments
|
| Zyla Life Sciences | Sprix | $29 | 2 payments
|
| Orthofix Medical | Galaxy Fixation | $20 | 1 payment
|
| Derma Sciences | Amnioexcel | $20 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $19 | 1 payment
|
| Osiris Therapeutics | Stravix | $18 | 1 payment
|
| Merck Sharp & Dohme | Sivextro | $18 | 1 payment
|
| Bioventus | Exogen | $16 | 1 payment
|
| Arthrosurface | Hemicap Mtp Resurfacing | $14 | 1 payment
|
| Medline Industries | Brace Ankle Brace Sport Medium Black | $11 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 0.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1770712101
- Licence
- CA E4988
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 213ES0103X (213ES0103X); Student in a training program (390200000X)
- Mailing address
- 16275 Monterey Rd Ste E, Morgan Hill, CA, 95037
- NPI first listed
- 2009-07-07
- NPI last updated
- 2020-01-19
- NPI record certified
- 2020-01-19
This is when the NPI record was last certified, not a medical board exam.